Albert David Ltd

Know More
NSEBSE

997.505.90 (0.59%)

03:45 PM,11th Dec 2023

1000.509.10 (0.92%)

04:01 PM,11th Dec 2023

BSE : 524075

NSE : ALBERTDAVD

Sector : Health care

ISIN Code : INE155C01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 11 2023 | 04:01 PM IST

Market Cap (₹ Cr)

569

Turnover (₹ Cr)

0.10

Volume (Shares)

10364

Face Value

10

52-WK High

1092.00

52-WK High Date

29 Nov 2023

52-WK Low

505.95

52-WK Low Date

31 Mar 2023

All Time High

1092.00

All Time High Date

29 Nov 2023

All Time Low

263.00

All Time Low Date

23 Mar 2020

Albert David Ltd

Incorporated in 1938 at Calcutta Albert David (ADL) is headed by Chairman A K Kothari. Its units at Calcutta Ghaziabad and Raisin manufacture pharmaceutical formulations including amino acid infusions. The company also manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals Japan a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani West Bengal to manufacture bulk drugs which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan Germany to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99 the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECARNIMERIL-TEVICTALROF-50. It is also planning to launch new products such as SIOOXYALAMIN FEZPANSURE.

Albert David Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

569

EPS - TTM (₹) [S]

101.70

P/E Ratio (X) [S]

1.63

Face Value (₹) 10
Latest Dividend (%)90.00
Latest Dividend Date 03 Aug 2023
Dividend Yield (%) 0.91
Book Value Share (₹) [S]613.47
P/B Ratio (₹) [S]1.63
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 23 0.02

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

991.00

1011.00

Week Low/High

985.05

1074.00

Month Low/High

835.00

1092.00

Year Low/High

505.95

1092.00

All time Low/High

3.15

1092.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.57%-2.84%1.541.50%
1 Month18.57%18.65%7.748.09%
3 Month28.04%28.26%4.175.00%
6 Month68.53%68.85%11.2612.68%
1 Year62.13%62.22%12.4613.52%
3 Year121.27%121.13%51.6955.37%

Company Info

Company Information

Executive Chairman : A K Kothari

Independent Director : Hemal Kampani

Independent Director : Rajiv Singhi

Director : Prabhawati Devi Kothari

Independent Director : Arindam Sarkar

Independent Director : Shirish Gundopant Belapure

Independent Director : Monjori Mitra

Director : Anand Vardhan Kothari

Company Sec. & Compli. Officer : A B Chakrabarty

Managing Director & CEO : U. M. Kunte

Registered Office: D Block 3rd Flr Gillander Hous, Netaji Subhas Road,Kolkata,West Bengal-700001 Ph: 91-33-22302330/2262 8436/8456/

Email:adidavid@dataone.in

URL:http://www.albertdavidindia.com